trial summary · NCT07907731
Effect of LMWH on Neonatal Outcomes in Isolated Oligohydramnios
Comparison of the Effect of Conventional Method Along With LMWH vs Conventional Method Alone in Improvement of Neonatal Outcomes in Pregnancies Complicated With Isolated Oligohydramnios in 2nd and 3rd Trimester.
Trial record from the TrialBase DB dataset, status RECRUITING, condition Oligohydramnios, sponsored by PAEC General Hospital, Islamabad. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
The pregnant women who meet the study requirements will be included in the study. They will be randomly assigned to receive either the usual treatment or the usual treatment along with an additional medicine. The usual treatment will include fluids given through a vein, rest while lying on the left side, and a low-dose aspirin tablet (75 mg once daily) from the 22nd to the 34th week of pregnancy. Women will also receive 1,000 ml of 5% dextrose fluid daily through a vein, from the time low amniotic fluid is diagnosed until the 36th week of pregnancy. Some women will also receive an additional injection of a blood-thinning medicine called low-molecular-weight heparin (LMWH), at a dose of 40 mg under the skin, from the 22nd to the 36th week of pregnancy. All participants will undergo weekly ultrasound examinations to measure the fluid surrounding the baby and assess blood flow through the umbilical cord. The study will record the number of babies born before 37 weeks of pregnancy, the babies' birth weights, and the number of babies born alive.
Source record: https://clinicaltrials.gov/study/NCT07907731
Facts
| registry id | NCT07907731 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE4 |
| study type | INTERVENTIONAL |
| lead condition | Oligohydramnios |
| sponsor | PAEC General Hospital, Islamabad |
| sponsor class | OTHER |
| enrollment | 106 |
| start date | 2026-10-24 |
| primary completion | 2027-01-25 |
| completion | 2027-01-30 |
| results posted | not reported |
Conditions
- Oligohydramnios
- Heparin
- Neonatal Outcomes
Interventions
- Enoxaparin (LMWH)
- Dextrose Water
Countries
- Pakistan
Intervention types: DRUG
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.